Tenofovir resistance among HIV-infected patients failing a fixed-dose combination of stavudine, lamivudine, and nevirapine in a resource-limited setting.
Sungkanuparph
Somnuek
S
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. rasuy@mahidol.ac.th
Manosuthi
Weerawat
W
Kiertiburanakul
Sasisopin
S
Chantratitra
Wasun
W
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D015331:Cohort Studies; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D008297:Male; D009154:Mutation; D019829:Nevirapine / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D063065:Organophosphonates / Q000494:pharmacology*; D018119:Stavudine / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D000068698:Tenofovir; D013785:Thailand; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D063065:Organophosphonates; D019259:Lamivudine; D019829:Nevirapine; D000068698:Tenofovir; D018119:Stavudine; D000225:Adenine